Work

A phase Ib dose escalation trial of SAR650984 (Anti-CD-38 mAb) in combination with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.8512

Authors: Thomas G. Martin, Karl Hsu, Eric Charpentier, Ravi Vij, Rachid C. Baz, Don M. Benson, Nikoletta Lendvai

Institutions: University of San Francisco, Washington University in St. Louis, Moffitt Cancer Center, The Ohio State University, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2698606705

Cites:

Cited by: 17

Related to: 10